CA Patent

CA2735899A1 — Liquid formulations of bendamustine

Assigned to Cephalon LLC · Expires 2010-04-01 · 16y expired

What this patent protects

Stable liquid formula-tions of bendamustine, and pharma-ceutically acceptable salts thereof, and polar aprotic solvents, are de-scribed.

USPTO Abstract

Stable liquid formula-tions of bendamustine, and pharma-ceutically acceptable salts thereof, and polar aprotic solvents, are de-scribed.

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2735899A1
Jurisdiction: CA
Classification: —
Expires: 2010-04-01
Drug substance claim: No
Drug product claim: No
Assignee: Cephalon LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.